Logo image of ABO.DE

CLEARVISE AG (ABO.DE) Stock Fundamental Analysis

Europe - FRA:ABO - DE000A1EWXA4 - Common Stock

1.61 EUR
0 (0%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

3

ABO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 22 industry peers in the Independent Power and Renewable Electricity Producers industry. ABO may be in some trouble as it scores bad on both profitability and health. ABO has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ABO had negative earnings in the past year.
In the past year ABO had a positive cash flow from operations.
Of the past 5 years ABO 4 years were profitable.
In the past 5 years ABO always reported a positive cash flow from operatings.
ABO.DE Yearly Net Income VS EBIT VS OCF VS FCFABO.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.37%, ABO is doing worse than 63.64% of the companies in the same industry.
The Return On Equity of ABO (-0.92%) is worse than 63.64% of its industry peers.
ABO has a worse Return On Invested Capital (0.76%) than 72.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABO is below the industry average of 5.43%.
Industry RankSector Rank
ROA -0.37%
ROE -0.92%
ROIC 0.76%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ABO.DE Yearly ROA, ROE, ROICABO.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

ABO has a Operating Margin (12.79%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ABO has declined.
Looking at the Gross Margin, with a value of 99.48%, ABO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 12.79%
PM (TTM) N/A
GM 99.48%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
ABO.DE Yearly Profit, Operating, Gross MarginsABO.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ABO is destroying value.
Compared to 1 year ago, ABO has about the same amount of shares outstanding.
Compared to 5 years ago, ABO has more shares outstanding
The debt/assets ratio for ABO is higher compared to a year ago.
ABO.DE Yearly Shares OutstandingABO.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABO.DE Yearly Total Debt VS Total AssetsABO.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

ABO has an Altman-Z score of 0.57. This is a bad value and indicates that ABO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.57, ABO is doing worse than 72.73% of the companies in the same industry.
ABO has a debt to FCF ratio of 12.04. This is a negative value and a sign of low solvency as ABO would need 12.04 years to pay back of all of its debts.
The Debt to FCF ratio of ABO (12.04) is better than 77.27% of its industry peers.
ABO has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
ABO's Debt to Equity ratio of 1.15 is in line compared to the rest of the industry. ABO outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 12.04
Altman-Z 0.57
ROIC/WACC0.2
WACC3.71%
ABO.DE Yearly LT Debt VS Equity VS FCFABO.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ABO has a Current Ratio of 0.81. This is a bad value and indicates that ABO is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ABO (0.81) is worse than 77.27% of its industry peers.
A Quick Ratio of 0.81 indicates that ABO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.81, ABO is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
ABO.DE Yearly Current Assets VS Current LiabilitesABO.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

ABO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -88.89%.
ABO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.53%.
Measured over the past years, ABO shows a small growth in Revenue. The Revenue has been growing by 1.75% on average per year.
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%-9.65%

3.2 Future

ABO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.72% yearly.
ABO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.57% yearly.
EPS Next Y213.43%
EPS Next 2Y51.42%
EPS Next 3Y40.72%
EPS Next 5YN/A
Revenue Next Year15.44%
Revenue Next 2Y13.51%
Revenue Next 3Y8.57%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ABO.DE Yearly Revenue VS EstimatesABO.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ABO.DE Yearly EPS VS EstimatesABO.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ABO. In the last year negative earnings were reported.
ABO is valuated quite expensively with a Price/Forward Earnings ratio of 199.26.
Based on the Price/Forward Earnings ratio, ABO is valued a bit more expensive than 72.73% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. ABO is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 199.26
ABO.DE Price Earnings VS Forward Price EarningsABO.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100

4.2 Price Multiples

ABO's Enterprise Value to EBITDA is on the same level as the industry average.
ABO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABO is cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.16
EV/EBITDA 15.39
ABO.DE Per share dataABO.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ABO's earnings are expected to grow with 40.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.42%
EPS Next 3Y40.72%

4

5. Dividend

5.1 Amount

ABO has a Yearly Dividend Yield of 3.61%. Purely for dividend investing, there may be better candidates out there.
ABO's Dividend Yield is rather good when compared to the industry average which is at 3.27. ABO pays more dividend than 81.82% of the companies in the same industry.
ABO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ABO.DE Yearly Dividends per shareABO.DE Yearly Dividends per shareYearly Dividends per share 2025 0.01 0.02 0.03 0.04 0.05

5.3 Sustainability

DP0%
EPS Next 2Y51.42%
EPS Next 3Y40.72%
ABO.DE Yearly Income VS Free CF VS DividendABO.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

CLEARVISE AG

FRA:ABO (9/19/2025, 7:00:00 PM)

1.61

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-14 2025-11-14
Inst Owners5.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap121.33M
Analysts85
Price Target2.82 (75.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.7%
PT rev (3m)-11.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)230.53%
EPS NY rev (3m)230.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.87%
Revenue NY rev (3m)-3.02%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 199.26
P/S 3.46
P/FCF 7.16
P/OCF 7.16
P/B 0.76
P/tB 0.76
EV/EBITDA 15.39
EPS(TTM)-0.01
EYN/A
EPS(NY)0.01
Fwd EY0.5%
FCF(TTM)0.22
FCFY13.97%
OCF(TTM)0.22
OCFY13.97%
SpS0.47
BVpS2.12
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.37%
ROE -0.92%
ROCE 1.25%
ROIC 0.76%
ROICexc 0.77%
ROICexgc 0.77%
OM 12.79%
PM (TTM) N/A
GM 99.48%
FCFM 48.29%
ROA(3y)2.27%
ROA(5y)1.33%
ROE(3y)6.14%
ROE(5y)3.7%
ROIC(3y)2.94%
ROIC(5y)2.51%
ROICexc(3y)3.51%
ROICexc(5y)2.93%
ROICexgc(3y)3.54%
ROICexgc(5y)2.98%
ROCE(3y)4.87%
ROCE(5y)4.15%
ROICexcg growth 3Y9.43%
ROICexcg growth 5Y-12.73%
ROICexc growth 3Y10.43%
ROICexc growth 5Y-12.09%
OM growth 3Y25.68%
OM growth 5Y-3.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5Y-0.49%
F-Score3
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 12.04
Debt/EBITDA 8.79
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 81.44%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 0.57
F-Score3
WACC3.71%
ROIC/WACC0.2
Cap/Depr(3y)122.48%
Cap/Depr(5y)90.46%
Cap/Sales(3y)45.96%
Cap/Sales(5y)37.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y213.43%
EPS Next 2Y51.42%
EPS Next 3Y40.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.53%
Revenue growth 3Y3.15%
Revenue growth 5Y1.75%
Sales Q2Q%-9.65%
Revenue Next Year15.44%
Revenue Next 2Y13.51%
Revenue Next 3Y8.57%
Revenue Next 5YN/A
EBIT growth 1Y-59.38%
EBIT growth 3Y29.64%
EBIT growth 5Y-1.33%
EBIT Next Year444.54%
EBIT Next 3Y84.01%
EBIT Next 5YN/A
FCF growth 1Y-214.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.76%
OCF growth 3Y-6.75%
OCF growth 5Y-8.15%